The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients

International Urology and Nephrology

Volumn 42, Issue 1, 2010, Pages 211-218

  Ertek, Sibel ^a,b   Torun, Ayse Nur ^a   Ates, Kenan ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b UFUK UNIVERSITY   (Turkey)

Author keywords

Atheroclerotic heart disease; Echocardiography; End stage renal disease; Homocysteine; Peritoneal dialysis; Pulse wave velocity

Indexed keywords

CREATININE; FIBRINOGEN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSATE; ECHOCARDIOGRAPHY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PULSE WAVE; TREATMENT DURATION;

ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PULSE; RISK FACTORS; YOUNG ADULT;

EID: 77950916697     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9625-y     Document Type: Article

References (46)

1. A Levin 2003 Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis Semin Dial 16 101 105 10.1046/j.1525-139X.2003. 16025.x 12641872 (Pubitemid 37361072)
2. MJ Sarnak AS Levey 1999 Epidemiology of cardiac disease in dialysis patients Semin Dial 12 69 76 10.1046/j.1525-139X.1999.00006.x
3. A Remppis E Ritz 2008 Cardiac problems in the dialysis patient: beyond coronary disease Semin Dial 21 319 325 10.1111/j.1525-139X.2008.00457.x 18627566
4. W Herrmann M Herrmann R Obeid 2007 Hyperhomocysteinaemia: a critical review of old and new aspects Curr Drug Metab 8 17 31 10.2174/138920007779315008 1:CAS:528:DC%2BD2sXisVyhsLw%3D 17266521 (Pubitemid 46043889)
5. R Clarke L Daly K Robinson, et al. 1991 Hyperhomocysteinemia: an independent risk factor for vascular disease N Engl J Med 324 1149 1155 1:STN:280:DyaK3M7oslSksw%3D%3D 2011158
6. GJ Hankey JW Eikelboom 1999 Homocysteine and vascular disease Lancet 354 407 413 10.1016/S0140-6736(98)11058-9 1:CAS:528:DyaK1MXlt1ajur0%3D 10437885 (Pubitemid 29355767)
7. B Hultberg A Andersson G Sterner 1993 Plasma homocysteine in renal failure Clin Nephrol 40 230 234 1:STN:280:DyaK2c%2FosV2rsA%3D%3D 8261681
8. A Moustapha A Gupta K Robinson, et al. 1999 Prevalance and determinants of hyper-homocysteinemia in hemodialysis and peritoneal dialysis Kidney Int 55 1470 1475 10.1046/j.1523-1755.1999.00378.x 1:STN:280:DyaK1M3hslSluw%3D%3D 10201012 (Pubitemid 29157146)
9. P Chauveau B Chadefaux M Coude, et al. 1993 Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients Kidney Int Suppl 41 S72 S77 1:STN:280:DyaK3szgvFSksQ%3D%3D 8320950 (Pubitemid 23165476)
10. K Robinson A Gupta V Dennis, et al. 1996 Hyper-homocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations Circulation 94 2743 2748 1:STN:280:DyaK2s%2Fps1Sktg%3D%3D 8941098 (Pubitemid 26411737)
11. M Fodinger H Buchmayer G Heinz, et al. 2001 Association of two MTHFR polymorphisms with total homcysteine plasma levels in dialysis patients Am J Kidney Dis 38 77 84 10.1053/ajkd.2001.25197 1:CAS:528:DC%2BD3MXlsVOls78%3D 11431185 (Pubitemid 32611762)
12. K Morimoto T Haneda K Okamoto H Ishida K Kikuchi 2002 Methylene-tetrahydrofolate reductase gene polymorphism, hyperhomocysteinemia, and cardiovascular diseases in chronic hemodialysis patients Nephon 90 43 50 10.1159/000046313 1:CAS:528:DC%2BD3MXptFClsbY%3D (Pubitemid 34042840)
13. S Gelev G Spasovski S Dzikova Z Trajkovski G Damjanovski V Amitov A Sikole 2008 Vascular calcification and atherosclerosis in hemodialysis patients: what can we learn from the routine clinical practice? Int Urol Nephrol 40 763 770 10.1007/s11255-008-9379-y 1:CAS:528:DC%2BD1cXptVChsrY%3D 18584302 (Epub 2008 Jun 27)
14. H Kocak S Gumuslu E Sahin, et al. 2009 Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in peritoneal dialysis patients Int Urol Nephrol 41 409 416 10.1007/s11255-008- 9504-y 1:STN:280:DC%2BD1MzisVKgtA%3D%3D 19115078 (Epub 2008 Dec 30)
15. J Blacher AP Guerin B Pannier SJ Marchais ME Safar GM London 1999 Impact of aortic stiffness on survival in end-stage renal disease Circulation 99 2434 2439 1:STN:280:DyaK1M3lt1WhtQ%3D%3D 10318666 (Pubitemid 29218240)
16. JN Cohn AA Quyyumi NK Holberg KA Jamerson 2004 Surrogate markers for cardiovascular disease: functional markers Circulation 109 25 Suppl 1 IV31 IV46 15226249
17. GM London SJ Marchais ME Safar AP Genest F Metivier K Chedid AM London 1990 Aortic and large artery compliance in end-stage renal disease Kidney Int 37 137 142 10.1038/ki.1990.19 1:STN:280:DyaK3c7jsVOgsg%3D%3D 2299800 (Pubitemid 20023778)
18. D Du Bois EF Du Bois 1989 A formula to estimate the approximate surface area if height and weight be known.1916 Nutrition 5 303 311 1:STN:280: DyaK387pvFyjsw%3D%3D 2520314
19. ME Charlson P Pompei KL Ales CR MacKenzie 1987 A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation J Chronic Dis 40 373 383 10.1016/0021-9681(87)90171-8 1:STN:280:DyaL2s7ms1GnsQ%3D%3D 3558716 (Pubitemid 17055592)
20. H Refsum T Fisherstrand AB Guttormsen PM Ueland 1997 Assessment of homocyteine status J Inherit Metab Dis 20 286 294 10.1023/A:1005321225893 1:STN:280:DyaK2szlsFSjtw%3D%3D 9211200 (Pubitemid 27273491)
21. RA Still IF McDowell 1998 Clinical implications of plasma homocysteine measurement in cardiovascular disease J Clin Pathol 51 183 188 10.1136/jcp.51.3.183 1:STN:280:DyaK1czitleqsQ%3D%3D 9659257
22. DJ Sahn A DeMaria J Kisslo A Weyman 1978 The committee on M-mode standardization of the American society of echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements Circulation 58 1072 1083 1:STN:280: DyaE1M%2Fktl2msw%3D%3D 709763
23. AG Bostom BF Culleton 1999 Hyperhomocysteinemia in chronic renal disease J Am Soc Nephrol 10 891 900 1:STN:280:DyaK1M3hvVSgug%3D%3D 10203375
24. C Chrysohoou DB Panagiotakos C Pitsavos, et al. 2004 The associations between smoking, physical activity, dietary habits and plasma homocysteine levels in cardiovascular disease free people: the 'ATTICA' study Vasc Med 9 117 123 10.1191/1358863x04vm542oa 15521701 (Pubitemid 39406426)
25. A Sobczak W Wardas W Zielinska-Danch K Pawlicki 2004 The influence of smoking on plasma homocysteine and cysteine levels in passive and active smokers Clin Chem Lab Med 42 408 414 10.1515/CCLM.2004.072 1:CAS:528: DC%2BD2cXjvVehsrk%3D 15147151 (Pubitemid 38585184)
26. J Tayama M Munakata K Yoshinaga T Toyota 2006 Higher plasma homocysteine concentration ia associated with more advanced ischemic arterial stiffness and greater blood pressure response to stress in hypertensive patients Hypertens Res 29 403 409 10.1291/hypres.29.403 1:CAS:528:DC%2BD28Xpt1ynsL4%3D 16940702 (Pubitemid 44102807)
27. E Coban M Ozdogan C ErmiS 2004 Plasma levels of homocysteine in patients with white-coat hypertension Int J Clin Pract 58 997 999 10.1111/j.1742-1241. 2004.00013.x 1:CAS:528:DC%2BD2MXhtlKqtb0%3D 15605659 (Pubitemid 39642406)
28. CD Stehouwer C van Guldener 2003 Does homocysteine cause hypertension? Clin Chem Lab Med 41 1408 1411 10.1515/CCLM.2003.216 1:CAS:528: DC%2BD3sXpsV2hsL8%3D 14656018 (Pubitemid 37493553)
29. Y Aso N Yoshida K Okumura, et al. 2004 Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia Clin Chim Acta 348 139 145 10.1016/j.cccn.2004.05.006 1:CAS:528:DC%2BD2cXnsFSksLs%3D 15369747 (Pubitemid 39209012)
30. SR Lentz 2005 Mechanisms of homcysteine induced atherothrombosis J Thromb Haemost 3 1646 1654 10.1111/j.1538-7836.2005.01364.x 1:CAS:528: DC%2BD2MXpsFGqu7g%3D 16102030 (Pubitemid 41716550)
31. AC Peeters BE van Aken HJ Blom PH Reitsma 2007 den Heijer M (2007) The effect of homocysteine reduction by B-vitamin supplementation on inflammatory markers Clin Chem Lab Med 45 47 53 10.1515/CCLM.2007.021 (Pubitemid 46155560)
32. GH Schernthaner C Plank E Minar C Bieglmayer R Koppensteiner 2006 Schernthaner G (2006) No effect of homocysteine lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease Eur J Clin Invest 36 333 339 10.1111/j.1365-2362.2006.01639.x 1:CAS:528: DC%2BD28XmtFOqsr8%3D 16634837
33. D McGregor B Shand K Lynn 2000 A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease Nephron 85 215 220 10.1159/000045664 1:CAS:528:DC%2BD3cXlsFGktrs%3D 10867536 (Pubitemid 30429325)
34. VD Alvares Delfino AC de Andrade Vianna AJ Mocelin DS Barbosa RA Mise T Matsuo 2007 Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients Nutiriton 23 242 247 (Pubitemid 46367571)
35. S Hirose R Kono T Mitarai K Isoda S Kim H Shimoyama 1999 Hyper-homocysteinemia in CAPD patients: peritoneal transport of total homocysteine at peritoneal equilibration test and daily elimination of total homocysteine Nippon Jinzo Gakkai Shi 41 778 786 1:STN:280:DC%2BD3c7itFWkuw%3D%3D 10655726
36. A Vychytil M Fodinger M Papagiannopoulos G Wölfl WH Hörl G Sunder-Plassmann 1999 Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis patients Kidney Int 55 2054 2061 10.1046/j.1523-1755.1999.00437.x 1:STN:280:DyaK1M3ltV2ksw%3D%3D 10231471 (Pubitemid 29197996)
37. DN Churchill DW Taylor PR Keshaviah The Canada-USA (CANUSA) Peritoneal Dialysis Study Group 1996 Adequacy of dialysis and nutrition in continuous ambulatory peritoneal dialysis patients J Am Soc Nephrol 7 198 207 (Pubitemid 26092470)
38. DW Johnson TD Kay DA Vesey N Isbel SB Campbell CM Hawley 2000 Peritoneal homocysteine clearance is inefficient in peritoneal dialysis patients Perit Dial Int 20 766 771 1:STN:280:DC%2BD3MzjslOhtQ%3D%3D 11216572
39. J Loscalzo 1996 The oxidant stress of hyperhomocysteinemia J Clin Invest 98 5 7 10.1172/JCI118776 1:CAS:528:DyaK28XktFWgsL4%3D 8690803
40. K Sydow B Hornig N Arakawa, et al. 2004 Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA Vasc Med 9 93 101 10.1191/1358863x04vm538oa 15521698 (Pubitemid 39406423)
41. M Cesari M Zanchetta A Burlina, et al. 2005 Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high risk coronary artery disease hypertensives Arterioscler Thromb Vasc Biol 25 115 121 1:CAS:528:DC%2BD2cXhtFaiu7jL 15528477 (Pubitemid 40054263)
42. S Laurent P Boutouyrie R Asmar, et al. 2001 Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients Hypertension 37 1236 1241 1:STN:280:DC%2BD3M3ptVWrsw%3D%3D 11358934 (Pubitemid 34163575)
43. J Blacher K Demuth AP Guerin ME Safar N Moatti GM London 1998 Influence of biochemical alterations on arterial stifness in patients with end-stage renal disease Arterioscler Thromb Vasc Biol 18 535 541 1:STN:280:DyaK1c3hsFWnsA%3D%3D 9555858 (Pubitemid 28177892)
44. S Zoungas P Branley PG Kerr, et al. 2004 Aterosclerosis and folic acid supplementation trial in chronic renal failure: baseline results Nephrology (Carlton) 9 130 141 10.1111/j.1440-1797.2004.00242.x 1:CAS:528: DC%2BD2MXitFWis7g%3D (Pubitemid 38887821)
45. LA Bortolotto ME Safar E Billaud, et al. 1999 Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients Hypertension 34 837 842 1:STN:280:DyaK1Mvlt1ymtg%3D%3D 10523370 (Pubitemid 29501309)
46. JV Woodside R McMahon AM Gallagher, et al. 2004 Total homocysteine is not a determinant of arterial pulse wave velocity in young healthy adults Atherosclerosis 177 337 344 10.1016/j.atherosclerosis.2004.07.001 1:CAS:528:DC%2BD2cXpsFeqsb4%3D 15530908 (Pubitemid 39505266)